Bango sees DVM momentum build as profits turn positive

About this episode

Bango PLC's CEO and CFO discuss the company's positive financial results and growth in subscription services.

Bango PLC (AIM:BGO, OTCQX:BGOPF) CEO Paul Larbey and CFO Matt Wilson joined Proactive's Stephen Gunnion to discuss their FY25 results and what Wilson called a "turning point" year — with revenue quality improving, cash EBITDA turning positive and new segmental reporting bringing greater transparency. The DVM platform delivered 60% subscription growth, zero customer churn and 12 new wins, with seven of the top eight US telcos now on board. Larbey highlighted the growing network effect: the more operators and content providers on the platform, the more valuable it becomes for everyone. Subscription bundling is increasingly resonating with consumers fatigued by fragmented services. Looking ahead, Bango sees expansion opportunities across telecoms, banking, retail and connected TV, with a 2027 target for the subscriptions division to reach positive cash earnings. For more insights, visit Proactive’s YouTube channel, like this video, subscribe, and enable notifications for future updates. #Bango #BangoPLC #DVM #DigitalVendingMachine #TechStocks #EarningsReport #SubscriptionEconomy #Telecom #Fintech #Investing #GrowthStocks #SaaS #PlatformBusiness #ProactiveInvestors #StockMarket

People in this episode

Host: Stephen Gunnion

Guests: Paul Larbey, Matt Wilson

Topics covered

• Bango
• DVM platform
• subscription growth
• telecoms
• financial results
• investing

Keywords

• Bango
• DVM
• subscription growth
• telecoms
• cash EBITDA
• investing
• financial results
• 2027 target

Mentioned in this episode

Organizations: Bango PLC, Proactive, US telcos, DVM, telecoms, banking, retail, connected TV

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min